National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

lomustine
A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis. This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing. Lomustine is lipophilic and crosses the blood-brain barrier. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Lomustinum
US brand name:CeeNU
Foreign brand names:Belustin
Belustine
Cecenu
Citostal
Lomeblastin
Lucostin
Lucostine
Prava
Abbreviation:CCNU
Code names:RB-1509
WR-139017
Chemical structure names:
  • 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea
  • Chloroethylcyclo-hexylnitrosourea
  • N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea



Previous:LMB-7 immunotoxin, LMB-9 immunotoxin, lobradimil, Lodine, lometrexol
Next:lonafarnib, lonaprisan, loperamide hydrochloride, lopinavir, lorazepam

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov